A phase II parallel group study with letrozole plus goserelin in premenopausal, and letrozole in postmenopausal metastatic breast cancer patients as first line hormone therapy
J. Ro, K.S. Lee, H. Han, E. Lee, H.S. Kang, S.W. Kim, Y. Kwon, B. NamVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70738-9
File:
PDF, 60 KB
english, 2008